Abiopharma

Clinical trial NCT07287670: start date: 2026-05-01 → 2026-04-16.

Clinical trial NCT03632941 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2025-12-01 → 2024-06-26 3. primary completion date: 2023-10-03 → 2023-09-03

Clinical trial NCT05791201 updates: 1. completion date: 2026-05-29 → 2027-03-12 2. primary completion date: 2026-05-29 → 2027-03-12

Clinical trial NCT07252050: start date: 2026-05-01 → 2026-06-08.

Clinical trial NCT07607613: intervention model: SINGLE_GROUP → PARALLEL.

Clinical trial NCT06060665 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-05-06 3. primary completion date: 2026-06-01 → 2026-05-06 4. enrollment: 90 → 96 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05784012 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. start date: 2023-11-08 → 2023-11-13 3. primary completion date: 2027-09-01 → 2027-03-01 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06847854: masking: DOUBLE → NONE.

Clinical trial NCT05858645 updates: 1. completion date: 2026-06-01 → 2028-06-01 2. primary completion date: 2026-06-01 → 2028-06-01

Clinical trial NCT05576896 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2028-07-01 → 2026-05-26 3. enrollment: 43 → 7 participants 4. enrollment type: ESTIMATED → ACTUAL